FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 20:45:03 06/06/2024 BST | ||
| 10.42 EUR | -4.75% |
|
| Current month | +10.62% | ||
| 1 month | +11.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 10.42 | -4.75% |
| 05/06/24 | 10.94 | +3.99% |
| 04/06/24 | 10.52 | +3.85% |
| 03/06/24 | 10.13 | +7.54% |
| 31/05/24 | 9.42 | +7.05% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BV |
| ISIN | DE000HD36BV2 |
| Date issued | 28/02/2024 |
| Strike | 154.7 $ |
| Maturity | Unlimited |
| Parity | 7.28 : 1 |
| Emission price | 10.47 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.09 € |
|---|---|
| Lowest since issue | 6.07 € |
| Spread | 0.04 € |
| Spread % | 0.39% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat
